These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Influence of maternal metabolic control and insulin antibodies on neonatal complications and B cell function in infants of diabetic mothers. Fallucca F, Maldonato A, Iavicoli M, Di Rollo G, Di Biase N, Napoli A, De Vecchis P, Sciullo E, Gerlinì G, Pachi A. Diabetes Res Clin Pract; 1989 Nov 06; 7(4):277-84. PubMed ID: 2693030 [Abstract] [Full Text] [Related]
5. Relationship between insulin antibodies and metabolic control in type I diabetes mellitus. Moisés RS, Sá JR, Chacra AR, Russo EM. Braz J Med Biol Res; 1990 Nov 06; 23(12):1243-52. PubMed ID: 2136556 [Abstract] [Full Text] [Related]
10. Cellular and humoural autoimmunity markers in type 2 (non-insulin-dependent) diabetic patients with secondary drug failure. Zavala AV, Fabiano de Bruno LE, Cardoso AI, Mota AH, Capucchio M, Poskus E, Fainboim L, Basabe JC. Diabetologia; 1992 Dec 06; 35(12):1159-64. PubMed ID: 1478368 [Abstract] [Full Text] [Related]
11. Erythrocyte Na/K ATPase activity and diabetes: relationship with C-peptide level. De La Tour DD, Raccah D, Jannot MF, Coste T, Rougerie C, Vague P. Diabetologia; 1998 Sep 06; 41(9):1080-4. PubMed ID: 9754827 [Abstract] [Full Text] [Related]
12. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group. J Clin Endocrinol Metab; 1987 Jul 06; 65(1):30-6. PubMed ID: 2884229 [Abstract] [Full Text] [Related]
13. Metabolic effect of islet B-cell function in insulin-treated diabetes. Gjessing HJ, Matzen LE, Iversen S, Faber OK, Frøland A. Scand J Clin Lab Invest; 1989 Jun 06; 49(4):337-43. PubMed ID: 2662383 [Abstract] [Full Text] [Related]
14. Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis. Wallensteen M, Dahlquist G, Persson B, Landin-Olsson M, Lernmark A, Sundkvist G, Thalme B. Diabetologia; 1988 Sep 06; 31(9):664-9. PubMed ID: 3069534 [Abstract] [Full Text] [Related]
15. A prospective study of glucose profiles, insulin antibody levels and beta cells secretory patterns in non-obese Ugandan diabetic subjects. Otim MA. East Afr Med J; 1988 Jan 06; 65(1):8-15. PubMed ID: 3046922 [No Abstract] [Full Text] [Related]
16. Heterogeneity of patients with latent autoimmune diabetes in adults: linkage to autoimmunity is apparent only in those with perceived need for insulin treatment: results from the Nord-Trøndelag Health (HUNT) study. Radtke MA, Midthjell K, Nilsen TI, Grill V. Diabetes Care; 2009 Feb 06; 32(2):245-50. PubMed ID: 19001190 [Abstract] [Full Text] [Related]
17. Seasonality of type 1 (insulin-dependent) diabetes mellitus: values of C-peptide, insulin antibodies and haemoglobin A1c show evidence of a more rapid loss of insulin secretion in epidemic patients. Ludvigsson J, Afoke AO. Diabetologia; 1989 Feb 06; 32(2):84-91. PubMed ID: 2656353 [Abstract] [Full Text] [Related]
18. Insulin--binding antibodies in Nigerian diabetic patients. Bella AF, Adetuyibi A. West Afr J Med; 1990 Feb 06; 9(4):291-4. PubMed ID: 2083207 [Abstract] [Full Text] [Related]
19. [The effect of anti-insulin antibodies and of peptide C residual secretion on the metabolic control of diabetes type 1]. Velasco N, Díaz de Valdés M, Arteaga A, Acosta AM, Pellegrini MR, Foradori A. Rev Med Chil; 1990 Jan 06; 118(1):3-9. PubMed ID: 2152698 [Abstract] [Full Text] [Related]
20. C-peptide in children with juvenile diabetes. A preliminary report. Ludvigsson J, Heding LG. Diabetologia; 1976 Dec 06; 12(6):627-30. PubMed ID: 1001852 [Abstract] [Full Text] [Related] Page: [Next] [New Search]